Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 3/2004

01-06-2004 | Letter to the Editor

Angiogenic factors in serum of patients with testicular germ cell tumours

Author: Simone Ferrero

Published in: Urolithiasis | Issue 3/2004

Login to get access

Excerpt

I read with interest the article by Bentas et al. [1] evaluating the serum levels of basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) in patients with testicular germ cell tumours. I would like to discuss some methodological problems that have arisen. …
Literature
1.
Bentas W, Beecken WD, Glienke W, Binder J, Schuldes H (2003) Serum levels of basic fibroblast growth factor reflect disseminated disease in patients with testicular germ cell tumors. Urol Res 30:390PubMed
2.
Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77:956PubMed
3.
Werther K, Christensen IJ, Nielsen HJ (2002) Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest 62:343CrossRefPubMed
4.
Hormbrey E, Gillespie P, Turner K, Han C, Roberts A, McGrouther D, Harris AL (2002) A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful? Clin Exp Metastasis 19:651CrossRefPubMed
5.
Pinedo HM, Verheul HM, D’Amato RJ, Folkman J (1998) Involvement of platelets in tumour angiogenesis? Lancet 352:1775CrossRefPubMed
6.
Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE (1998) Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 94:395
7.
Dittadi R, Meo S, Fabris F, Gasparini G, Contri D, Medici M, Gion M (2001) Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments. Int J Biol Markers 16:87PubMed
Metadata
Title
Angiogenic factors in serum of patients with testicular germ cell tumours
Author
Simone Ferrero
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 3/2004
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-004-0433-7

Other articles of this Issue 3/2004

Urolithiasis 3/2004 Go to the issue

Original Paper

The effects of chronic exposure to ethanol and cigarette smoke on the level of reduced glutathione and malondialdehyde in rat kidney

Book Review

Gout—the “at your finger tips” guide by R. Grahame, H.A. Simmonds, E. Carrey

Original Paper

Nocturia and complementary indices: determination and quantification of the cause of nocturia by frequency-volume charts in women with lower urinary tract symptoms

Original Paper

Biochemical analysis of urethral collagen content after tubularized incised plate urethroplasty: an experimental study in rabbits

Original Paper

Testicular tissue nitric oxide and thiobarbituric acid reactive substance levels: evaluation with respect to the pathogenesis of varicocele

Original Paper

Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats